Effect of Wnt/Ý-catenin pathway alteration in hepatocellular carcinoma cell lines and the possible modulation by bevacizumab / Reem Mahmoud Mohammad Mebed ; Supervised Salwa Farouk Sabet , Nahla Shehata Kotb
Material type: TextLanguage: English Publication details: Cairo : Reem Mahmoud Mohammad Mebed , 2021Description: 89 P. : charts , facsimiles ; 25cmOther title:- تاثير تغيير مسار الونت بيتا كاتينين على خطوط خلايا سرطان الكبد البشرى والتحوير المحتمل بواسطة البيفاسيزوماب [Added title page title]
- Issued also as CD
Item type | Current library | Home library | Call number | Copy number | Status | Date due | Barcode | |
---|---|---|---|---|---|---|---|---|
Thesis | قاعة الرسائل الجامعية - الدور الاول | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.12.21.Ph.D.2021.Re.E (Browse shelf(Opens below)) | Not for loan | 01010110085096000 | |||
CD - Rom | مخـــزن الرســائل الجـــامعية - البدروم | المكتبة المركزبة الجديدة - جامعة القاهرة | Cai01.12.21.Ph.D.2021.Re.E (Browse shelf(Opens below)) | 85096.CD | Not for loan | 01020110085096000 |
Browsing المكتبة المركزبة الجديدة - جامعة القاهرة shelves Close shelf browser (Hides shelf browser)
Thesis (Ph.D.) - Cairo University - Faculty of Science - Department of Zoology
As about 90% of colorectal cancers and 50% of hepatocellular carcinoma have activated Wnt/Ý-catenin signaling, the current study aim to examine the effect of knocking down Ý-catenin on the expression of VEGF-A and Slug as well as the apoptosis related genes; NF-mB, FasR and c-Flip in HepG2 cells and the possible alteration of their expression when combined with Bevacizumab. Expression of VEGF-A and Slug was also studied in Caco-2 cells. It is reported in this study that VEGF-A increases significantly in response to Bevacizumab alone in HepG2, while VEGF-A and Slug decreased significantly when Bevacizumab was combined with knocked down Ý-catenin in HepG2. However, Bevacizumab alone is more effective in reducing the expression of those genes in Caco-2. On the other hand, Bevacizumab combined with knocked down Ý-catenin remarkably reduced the level of NF-mB, FasR and c-Flip compared to Bevacizumab only treated HepG2 cells although the difference was not statistically significant
Issued also as CD
There are no comments on this title.